McMeans Shaun D
Transaction: 07/23/2026
OTHER
Change
0
Price
Not reported
Filing
07/29/2026
Type
OTHER
Vaso Corporation
VASO • Medical - Healthcare Information Services
$0.31
▲ +0.02 (+7.28%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$54.25M
Growth
11.9%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 0.05Consistent free cash flow · 5/5Reasonable earnings multiple · 19.6Manageable debt level · 0.06Healthy liquidity · 1.59
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.31
Change7.28%
Shares Out175.00M
Market Cap$54.25M
Enterprise Value$33.70M
52W Range0.11 - 0.28
Beta0.64
P/E19.42
P/S0.68
P/B1.90
P/FCF-14.47
EV/Sales0.42
Price$0.31
Change7.28%
Shares Out175.00M
Market Cap$54.25M
Enterprise Value$33.70M
52W Range0.11 - 0.28
Beta0.64
P/E19.42
P/S0.68
P/B1.90
P/FCF-14.47
EV/Sales0.42
EV/EBITDA79.47
EV/FCF-8.99
Earnings Yield5.15%
FCF Yield-6.91%
Dividend Yield0.00%
Gross Margin61.36%
Oper. Margin1.96%
Profit Margin1.76%
Debt/Eq0.06
Current Ratio1.59
Quick Ratio1.57
Revenue 5Y11.87%
Volume129.67K
Avg Volume158.93K
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
60
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
91/100
Growth Potential
Revenue and expansion
54/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Positive free cash flow · 0.05Consistent free cash flow · 5/5Reasonable earnings multiple · 19.6Manageable debt level · 0.06Healthy liquidity · 1.59Weak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Ma Jun
Transaction: 11/21/2024
BUY
Change
+200,000
Price
$0.13
Filing
11/22/2024
Type
BUY
Dembo Leon
Transaction: 11/15/2024
BUY
Change
+150,000
Price
Not reported
Filing
11/19/2024
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| McMeans Shaun D | OTHER | 0 | Not reported | 07/23/2026 | 07/29/2026 |
| Ma Jun | BUY | +200,000 | $0.13 | 11/21/2024 | 11/22/2024 |
| Dembo Leon | BUY | +150,000 | Not reported | 11/15/2024 | 11/19/2024 |
| Markowitz Joshua | BUY | +55,738,318 | Not reported | 04/17/2023 | 12/11/2023 |
| Dembo Leon | OTHER | 0 | Not reported | 04/03/2023 | 04/03/2023 |
| Moen Janey | SELL | 0 | Not reported | 06/01/2018 | 03/11/2021 |
| Moen Janey | SELL | 0 | Not reported | 03/25/2020 | 04/07/2020 |
| Newton Jonathan P | BUY | +500,000 | Not reported | 12/30/2019 | 12/30/2019 |
| Ma Jun | BUY | +5,000,000 | Not reported | 06/21/2019 | 06/25/2019 |
| Ma Jun | BUY | +50,000 | $0.05 | 08/20/2018 | 08/20/2018 |
| Ma Jun | BUY | +30,000 | $0.05 | 08/17/2018 | 08/20/2018 |
| Ma Jun | BUY | +38,305 | $0.04 | 08/16/2018 | 08/20/2018 |
| Newton Jonathan P | BUY | +50,000 | Not reported | 03/20/2018 | 04/19/2018 |
| BEECHER MICHAEL | BUY | +75,000 | Not reported | 03/20/2018 | 03/22/2018 |
| Ma Jun | BUY | +300,000 | Not reported | 03/20/2018 | 03/22/2018 |
| CASTLE PETER C | BUY | +300,000 | Not reported | 03/20/2018 | 03/22/2018 |
| Newton Jonathan P | BUY | +50,000 | Not reported | 03/29/2017 | 03/22/2018 |
| Ma Jun | BUY | +150,000 | $0.06 | 12/05/2017 | 12/05/2017 |
| BEECHER MICHAEL | BUY | +75,000 | Not reported | 03/29/2017 | 03/31/2017 |
| CASTLE PETER C | BUY | +400,000 | Not reported | 03/29/2017 | 03/31/2017 |